Jun Fujimoto

Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response

Akito Nakamura, Tadahiro Nambu, Shunsuke Ebara et al. · Proceedings of the National Academy of Sciences · 2018 · 170 citations · Full text

Medicine, Oncology, Pharmacology +16

Advantage of in situ generation of N-arylsulfonyl imines from α-amide sulfones in the phase-transfer-catalyzed asymmetric Strecker reaction

Takashi Ooi, Yukitaka Uematsu, Jun Fujimoto et al. · Tetrahedron Letters · 2006 · 66 citations

Natural Sciences, Chemistry, Medicinal Chemistry +5

DNA Alkylation by Pyrrole−Imidazole <i>seco</i>-CBI Conjugates with an Indole Linker:  Sequence-Specific DNA Alkylation with 10-Base-Pair Recognition through Heterodimer Formation

Masafumi Minoshima, Toshikazu Bando, Shunta Sasaki et al. · Journal of the American Chemical Society · 2007 · 44 citations

Pharmacy, Chemical Biology, Molecular Biology +15

Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode

Jun Fujimoto, Osamu Kurasawa, Terufumi Takagi et al. · ACS Medicinal Chemistry Letters · 2019 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Aerosolization of lipoplexes using AERx® pulmonary delivery system

Deepa Deshpande, James Blanchard, Sudarshan Srinivasan et al. · AAPS PharmSci · 2002 · 36 citations · Full text

Pharmacy, Molecular Biology, Pharmaceutics +17